Johnson & Johnson Vaccine on Hold

This week, the FDA decided to pause the Johnson & Johnson vaccine following reports that  six women—of the nearly 7 million Americans who have received the J&J vaccine—developed serious blood clots after getting the jab. Is pausing the vaccine worth the tradeoffs? Will the FDA’s move fuel vaccine hesitancy? Sarah, David, Chris and Jonah give us the scoop. Today, our hosts also chat about New York Times columnist Ross Douthat’s latest piece on what Bidenism owes to Trumpism, the GOP’s First Amendment retribution against woke corporations, and what Democratic pollsters have learned from their poor electoral forecasting leading up to the 2020 election.

Show Notes:

Join to continue reading
Get started with a free account or join as a member for unlimited access to all of The Dispatch. Continue ALREADY HAVE AN ACCOUNT? SIGN IN